Population pharmacokinetics and exposure‐response relationship for temsavir following fostemsavir administration in treatment‐experienced HIV patients

Abstract Fostemsavir (FTR, GSK3684934; formerly BMS‐663068) is a human immunodeficiency virus type 1 (HIV‐1) attachment inhibitor approved for the treatment of multidrug‐resistant HIV‐1 infection in heavily treatment‐experienced (HTE) patients failing their current antiretroviral regimen. FTR is an...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Ridhi Parasrampuria, Nilay Thakkar, Katy Moore, Peter Ackerman, Mindy Magee
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wiley 2025-06-01
Schriftenreihe:	Pharmacology Research & Perspectives
Schlagworte:	exposure response fostemsavir HIV‐1 population PK
Online-Zugang:	https://doi.org/10.1002/prp2.70023
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!